Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Study cracks the cold case of immunotherapy resistance December 3, 2024 Casual blood glucose test misses majority of gestational diabetes cases September 18, 2024 Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency January 17, 2025